BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18218239)

  • 41. Relationship between serum secreted frizzled-related protein 4 levels and the first-phase of glucose-stimulated insulin secretion in individuals with different glucose tolerance.
    Liu F; Qu H; Li Y; Tang Q; Yang Z; Wang H; Deng H
    Endocr J; 2015; 62(8):733-40. PubMed ID: 26041556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of novel biomarkers to monitor β-cell function and enable early detection of type 2 diabetes risk.
    Belongie KJ; Ferrannini E; Johnson K; Andrade-Gordon P; Hansen MK; Petrie JR
    PLoS One; 2017; 12(8):e0182932. PubMed ID: 28846711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function.
    Mari A; Manco M; Guidone C; Nanni G; Castagneto M; Mingrone G; Ferrannini E
    Diabetologia; 2006 Sep; 49(9):2136-43. PubMed ID: 16819611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance.
    Larsson H; Ahrén B
    Diabetologia; 1996 Sep; 39(9):1099-107. PubMed ID: 8877295
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism Study.
    Gastaldelli A; Gaggini M; DeFronzo RA
    Diabetes; 2017 Apr; 66(4):815-822. PubMed ID: 28052966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
    Hung YJ; Lin SH; Pei D; Kuo SW; Hsieh CH; He CT; Hsing Lee C; Fan SC; Sheu WH
    Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of a family history of type 2 diabetes on insulin secretion and insulin sensitivity in individuals with varying glucose tolerance.
    Li P; Zhang JF; Li L; Liu YH; Shi Y; Wang LW; Gao JQ; Liu C
    Am J Med Sci; 2013 Jan; 345(1):22-7. PubMed ID: 22543593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucose effectiveness in two subtypes within impaired glucose tolerance. A minimal model analysis.
    Taniguchi A; Nakai Y; Doi K; Fukushima M; Nagata I; Kawamura H; Imura H; Suzuki M; Tokuyama K
    Diabetes; 1994 Oct; 43(10):1211-7. PubMed ID: 7926290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Worse pancreatic β-cell function and better insulin sensitivity in older Chinese without diabetes.
    Xiao J; Weng J; Ji L; Jia W; Lu J; Shan Z; Liu J; Tian H; Ji Q; Yang Z; Yang W;
    J Gerontol A Biol Sci Med Sci; 2014 Apr; 69(4):463-70. PubMed ID: 23974206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Singapore impaired glucose tolerance follow-up study: does the ticking clock go backward as well as forward?
    Wong MS; Gu K; Heng D; Chew SK; Chew LS; Tai ES
    Diabetes Care; 2003 Nov; 26(11):3024-30. PubMed ID: 14578234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1).
    Snehalatha C; Mary S; Selvam S; Sathish Kumar CK; Shetty SB; Nanditha A; Ramachandran A
    Diabetes Care; 2009 Oct; 32(10):1796-801. PubMed ID: 19587369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels.
    Marini MA; Succurro E; Frontoni S; Mastroianni S; Arturi F; Sciacqua A; Lauro R; Hribal ML; Perticone F; Sesti G
    Diabetes Care; 2012 Apr; 35(4):868-72. PubMed ID: 22357182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents.
    Cali AM; Man CD; Cobelli C; Dziura J; Seyal A; Shaw M; Allen K; Chen S; Caprio S
    Diabetes Care; 2009 Mar; 32(3):456-61. PubMed ID: 19106382
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of Japanese subjects who progress from normal to impaired glucose tolerance. Longitudinal study excluding changes in body weight.
    Igarashi Y; Mita T; Mizuno R; Watada H; Tanaka Y; Kawamori R; Hirose T
    Endocr J; 2005 Dec; 52(6):683-9. PubMed ID: 16410659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlates.
    Defronzo RA; Tripathy D; Schwenke DC; Banerji M; Bray GA; Buchanan TA; Clement SC; Gastaldelli A; Henry RR; Kitabchi AE; Mudaliar S; Ratner RE; Stentz FB; Musi N; Reaven PD;
    Diabetes; 2013 Nov; 62(11):3920-6. PubMed ID: 23863810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of glucose tolerance status, sex, and body size on glucose absorption patterns during OGTTs.
    Færch K; Pacini G; Nolan JJ; Hansen T; Tura A; Vistisen D
    Diabetes Care; 2013 Nov; 36(11):3691-7. PubMed ID: 24062321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance.
    Mari A; Tura A; Natali A; Laville M; Laakso M; Gabriel R; Beck-Nielsen H; Ferrannini E;
    Diabetologia; 2010 Apr; 53(4):749-56. PubMed ID: 20225397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucose intolerance in acromegaly is driven by low insulin secretion; results from an intravenous glucose tolerance test.
    Zaifu LG; Niculescu DA; Kremer AE; Caragheorgheopol A; Sava M; Iordachescu CN; Dusceac R; Burcea IF; Poiana C
    Pituitary; 2024 Apr; 27(2):178-186. PubMed ID: 38381238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation.
    Hjelmesaeth J; Hagen M; Hartmann A; Midtvedt K; Egeland T; Jenssen T
    Clin Transplant; 2002 Dec; 16(6):389-96. PubMed ID: 12437616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.